RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
180 Life Sciences Stock

180 Life Sciences ROA 2024

180 Life Sciences ROA

-3.79

Ticker

ATNF

ISIN

US68236V1044

WKN

A2QJX5

In 2024, 180 Life Sciences's return on assets (ROA) was -3.79, a 92.34% increase from the -1.97 ROA in the previous year.

180 Life Sciences Aktienanalyse

What does 180 Life Sciences do?

180 Life Sciences Corp is a US biotechnology company that focuses on the development of treatments for chronic inflammatory diseases. The company was founded in 2018 and is headquartered in New York City. 180 Life Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding 180 Life Sciences's Return on Assets (ROA)

180 Life Sciences's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing 180 Life Sciences's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider 180 Life Sciences's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in 180 Life Sciences’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about 180 Life Sciences stock

What is the Return on Assets (ROA) of 180 Life Sciences this year?

The Return on Assets (ROA) of 180 Life Sciences is -3.79 undefined this year.

What was the ROA of 180 Life Sciences compared to the previous year?

The ROA of 180 Life Sciences has increased by 92.34% compared to the previous year.

What consequences do high ROA have for investors of 180 Life Sciences?

A high ROA is advantageous for investors of 180 Life Sciences, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in 180 Life Sciences?

A low ROA can be unfavorable for investors of 180 Life Sciences as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of 180 Life Sciences affect the company?

An increase in ROA of 180 Life Sciences can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of 180 Life Sciences impact the company?

A reduction in the ROA of 180 Life Sciences can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of 180 Life Sciences?

Some factors that can influence the ROA of 180 Life Sciences include revenue, operating costs, asset structure, and industry average.

Why is the ROA of 180 Life Sciences important for investors?

The ROA of 180 Life Sciences is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can 180 Life Sciences take to improve ROA?

To improve ROA, 180 Life Sciences can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does 180 Life Sciences pay?

Over the past 12 months, 180 Life Sciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, 180 Life Sciences is expected to pay a dividend of 0 USD.

What is the dividend yield of 180 Life Sciences?

The current dividend yield of 180 Life Sciences is .

When does 180 Life Sciences pay dividends?

180 Life Sciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of 180 Life Sciences?

180 Life Sciences paid dividends every year for the past 0 years.

What is the dividend of 180 Life Sciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is 180 Life Sciences located?

180 Life Sciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von 180 Life Sciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of 180 Life Sciences from 9/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/19/2024.

When did 180 Life Sciences pay the last dividend?

The last dividend was paid out on 9/19/2024.

What was the dividend of 180 Life Sciences in the year 2023?

In the year 2023, 180 Life Sciences distributed 0 USD as dividends.

In which currency does 180 Life Sciences pay out the dividend?

The dividends of 180 Life Sciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von 180 Life Sciences

Our stock analysis for 180 Life Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of 180 Life Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.